Bumper Offer - Urjas oil Just @ Rs. 1
StayHappi Rosuvastatin + Fenofibrate Tablet is an allopathic medicine The correct dosage of StayHappi Rosuvastatin + Fenofibrate Tablet depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
StayHappi Rosuvastatin + Fenofibrate Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when StayHappi Rosuvastatin + Fenofibrate Tablet is used -
Moderate
Common
Is the use of StayHappi Rosuvastatin + Fenofibrate Tablet safe for pregnant women?
StayHappi Rosuvastatin + Fenofibrate Tablet can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking StayHappi Rosuvastatin + Fenofibrate Tablet right away. Take your doctor's advice before taking it again.
Is the use of StayHappi Rosuvastatin + Fenofibrate Tablet safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of StayHappi Rosuvastatin + Fenofibrate Tablet. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of StayHappi Rosuvastatin + Fenofibrate Tablet on the Kidneys?
StayHappi Rosuvastatin + Fenofibrate Tablet rarely harms the kidneys.
What is the effect of StayHappi Rosuvastatin + Fenofibrate Tablet on the Liver?
StayHappi Rosuvastatin + Fenofibrate Tablet may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of StayHappi Rosuvastatin + Fenofibrate Tablet on the Heart?
StayHappi Rosuvastatin + Fenofibrate Tablet can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
StayHappi Rosuvastatin + Fenofibrate Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take StayHappi Rosuvastatin + Fenofibrate Tablet unless your doctor advises you to do so -
Is this StayHappi Rosuvastatin + Fenofibrate Tablet habit forming or addictive?
No, there is no any evidence that StayHappi Rosuvastatin + Fenofibrate Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking StayHappi Rosuvastatin + Fenofibrate Tablet. So it is best to avoid driving.
Is it safe?
Yes, but consume StayHappi Rosuvastatin + Fenofibrate Tablet only on doctor's advice.
Is it able to treat mental disorders?
No, StayHappi Rosuvastatin + Fenofibrate Tablet cannot treat any kind of mental disorder.
Interaction between Food and StayHappi Rosuvastatin + Fenofibrate Tablet
Information is not available on the interaction of any foods with StayHappi Rosuvastatin + Fenofibrate Tablet, due to a lack of research on this.
Interaction between Alcohol and StayHappi Rosuvastatin + Fenofibrate Tablet
No research has been done on this till date. Therefore, it is not known what the effect of taking StayHappi Rosuvastatin + Fenofibrate Tablet with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Triglide (fenofibrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 639-640
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 551-552
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Triglide (fenofibrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 639-640
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 551-552
